These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35857046)

  • 21. Screening methods for rapid determination of new psychoactive substances (NPS) in conventional and non-conventional biological matrices.
    Graziano S; Anzillotti L; Mannocchi G; Pichini S; Busardò FP
    J Pharm Biomed Anal; 2019 Jan; 163():170-179. PubMed ID: 30316062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid chromatography-tandem mass spectrometry screening method using information-dependent acquisition of enhanced product ion mass spectra for synthetic cannabinoids including metabolites in urine.
    Staeheli SN; Veloso VP; Bovens M; Bissig C; Kraemer T; Poetzsch M
    Drug Test Anal; 2019 Sep; 11(9):1369-1376. PubMed ID: 31219237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Novel Psychoactive Substances on Clinical and Forensic Toxicology and Global Public Health.
    Huestis MA; Brandt SD; Rana S; Auwärter V; Baumann MH
    Clin Chem; 2017 Oct; 63(10):1564-1569. PubMed ID: 28667187
    [No Abstract]   [Full Text] [Related]  

  • 24. Multi-class analysis of new psychoactive substances and metabolites in hair by pressurized liquid extraction coupled to HPLC-HRMS.
    Montesano C; Vannutelli G; Massa M; Simeoni MC; Gregori A; Ripani L; Compagnone D; Curini R; Sergi M
    Drug Test Anal; 2017 May; 9(5):798-807. PubMed ID: 27448433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology - An update.
    Remane D; Wissenbach DK; Peters FT
    Clin Biochem; 2016 Sep; 49(13-14):1051-71. PubMed ID: 27452180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Editorial: Advances and Future Developments in Forensic Toxicology: From Standard Practices to New Psychoactive Substances.
    Busardo FP; Pichini S; Peters FT
    Curr Pharm Des; 2017; 23(36):5427-5428. PubMed ID: 29237370
    [No Abstract]   [Full Text] [Related]  

  • 27. Collaboration of the Joint Research Centre and European Customs Laboratories for the Identification of New Psychoactive Substances.
    Guillou C; Reniero F; Lobo Vicente J; Holland M; Kolar K; Chassaigne H; Tirendi S; Schepers H
    Curr Pharm Biotechnol; 2018; 19(2):91-98. PubMed ID: 29792142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel screening method for 64 new psychoactive substances and 5 amphetamines in blood by LC-MS/MS and application to real cases.
    Vaiano F; Busardò FP; Palumbo D; Kyriakou C; Fioravanti A; Catalani V; Mari F; Bertol E
    J Pharm Biomed Anal; 2016 Sep; 129():441-449. PubMed ID: 27490334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigating the appearance of new psychoactive substances in South Australia using wastewater and forensic data.
    Bade R; Stockham P; Painter B; Celma A; Bijlsma L; Hernandez F; White JM; Gerber C
    Drug Test Anal; 2019 Feb; 11(2):250-256. PubMed ID: 30129282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-throughput screening for new psychoactive substances (NPS) in whole blood by DLLME extraction and UHPLC-MS/MS analysis.
    Odoardi S; Fisichella M; Romolo FS; Strano-Rossi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1000():57-68. PubMed ID: 26209771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous Determination of Amphetamine-Related New Psychoactive Substances in Urine by Gas Chromatography-Mass Spectrometry.
    Kim JY; Suh S; Park J; In MK
    J Anal Toxicol; 2018 Nov; 42(9):605-616. PubMed ID: 29982540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of the COVID-19 pandemic on the use of the performance-enhancing drugs.
    Negro F; Di Trana A; Marinelli S
    Acta Biomed; 2022 Jan; 92(6):e2021401. PubMed ID: 35075058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug screening in clinical or forensic toxicology: are there differences?
    Gerostamoulos D; Beyer J
    J Law Med; 2010 Sep; 18(1):25-8. PubMed ID: 20977157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of a rapid LC-MS/MS method for the detection of 182 novel psychoactive substances in whole blood.
    Giorgetti A; Barone R; Pelletti G; Garagnani M; Pascali J; Haschimi B; Auwärter V
    Drug Test Anal; 2022 Feb; 14(2):202-223. PubMed ID: 34599648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous Screening and Quantification of Basic, Neutral and Acidic Drugs in Blood Using UPLC-QTOF-MS.
    Bidny S; Gago K; Chung P; Albertyn D; Pasin D
    J Anal Toxicol; 2017 Apr; 41(3):181-195. PubMed ID: 27881618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection and quantification of synthetic cathinones and selected piperazines in hair by LC-MS/MS.
    Niebel A; Krumbiegel F; Hartwig S; Parr MK; Tsokos M
    Forensic Sci Med Pathol; 2020 Mar; 16(1):32-42. PubMed ID: 31853826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of a molecular networking approach for clinical and forensic toxicology exemplified in three cases involving 3-MeO-PCP, doxylamine, and chlormequat.
    Allard S; Allard PM; Morel I; Gicquel T
    Drug Test Anal; 2019 May; 11(5):669-677. PubMed ID: 30468699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenges Related to Three Cases of Fatal Intoxication to Multiple Novel Synthetic Opioids.
    Garneau B; Desharnais B; Beauchamp-Doré A; Lavallée C; Mireault P; Lajeunesse A
    J Anal Toxicol; 2020 Jan; 44(1):86-91. PubMed ID: 30927001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrospective drug detection in cases of drug-facilitated sexual assault: challenges and perspectives for the forensic toxicologist.
    Parkin MC; Brailsford AD
    Bioanalysis; 2009 Aug; 1(5):1001-13. PubMed ID: 21083067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxicology in international drug control-Prioritizing the most harmful, persistent and prevalent substances.
    Ifeagwu SC; Raithelhuber M; Crean C; Gerostamoulos D; Chung H; Tettey JN
    Forensic Sci Int; 2017 May; 274():2-6. PubMed ID: 27899215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.